Loading chat...
GA SB370
Bill
Status
Introduced
2/10/2014
Primary Sponsor
Earl Carter
Click for details
AI Summary
- Adds definitions for "biological product" and "interchangeable biological product" to Georgia pharmacy law, with interchangeable biological products being those the FDA has determined meet safety standards under 42 U.S.C. Section 262(k)(4) and may be substituted without prescriber intervention
- Authorizes pharmacists to substitute an interchangeable biological product for a prescribed brand name biological product, provided the route of administration, dosage form, and strength are the same and the pharmacist deems it pharmaceutically equivalent
- Requires pharmacists who substitute an interchangeable biological product to record the substitution on the original prescription and label the container with both the brand name and nonproprietary name along with language indicating the substitution occurred
- Allows patients to instruct pharmacists not to substitute an interchangeable biological product, and allows prescribers to prevent substitution by writing "brand necessary" on the prescription
- Clarifies that substitution of a biological product by a pharmacist under these provisions does not constitute the practice of medicine
Legislative Description
Pharmacists and Pharmacies; define certain terms; provide substitutions of interchangeable biological products
Last Action
Senate Read and Referred
2/11/2014
Full Bill Text
No bill text available